Faculty profile

Ramana Appireddy

ResearcherMedicineQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses and email address may be missing. Find their university profile.

Ramana Appireddy

Researcher

Medicine

Health Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
34 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

895

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Evisits Home Video Visits Telemedicine Virtual Care Virtual Health

Latest papers

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial.
Neurology · 2026
Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.
Stroke · 2026
Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
Stroke · 2025

All 45 publications

Latest funding

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
CIHR · 2024 · Co-investigator
$248,624
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Co-investigator
$4,048,545
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Co-investigator
$1,012,136

All 8 grants and awards

45 publications.

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial.

Ganesh A, Vatanpour S, Yu AYX, Barber P, Choi PMC, Field TS, Kate MP, Kleinig TJ, Shamy MCF, Chatterjee K, Molina CA, Campbell BCV, Appireddy R, Muir KW, Hill MD, Coutts SB, as the TEMPO-2 investigators

Neurology2026

DOI: 10.1212/wnl.0000000000214925 PMID: 41980227

Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.

Massicotte S, Vatanpour S, Doolan C, Zhang J, Ganesh A, Choi PMC, Buck BH, Field TS, Yu AYX, Kleinig TJ, Muir KW, Campbell BCV, Molina CA, Appireddy R, Hill MD, Singh N, Coutts SB, TEMPO-2 Investigators

Stroke2026

DOI: 10.1161/strokeaha.125.054491 PMID: 41958392

Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Perera KS, Sharma MA, Eikelboom JW, Ng KKH, Field TS, Buck BH, Hill MD, Stotts G, Casaubon LK, Mandzia J

Stroke202514 citations

DOI: 10.1161/strokeaha.124.047715

Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial

Singh N, Bala F, Ademola A, Almekhlafi M, Coutts SB, Deschaintre Y, Khosravani H, Buck BH, Appireddy R, Moreau F

Stroke20257 citations

DOI: 10.1161/strokeaha.124.049512

Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

Sujanthan S, Puveendrakumaran P, Dainty KN, Barense M, Lanctot KL, Owen AM, Singh N, Buck BH, Khosravani H, Coutts SB

European Stroke Journal20257 citations

DOI: 10.1177/23969873251323171

The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial

Kaveeta C, Alhabli I, Bala F, Horn M, Benali F, Coutts SB, Zafar A, Bereznyakova O, Khaw A, Khosravani H

International Journal of Stroke20256 citationsOpen Access

DOI: 10.1177/17474930241273561 PMID: W4401228556

Intravenous tenecteplase is associated with a higher incidence of thrombus movement before endovascular treatment for acute ischemic stroke: a secondary analysis of the AcT randomized controlled trial

Alhabli I, Ishaque N, Kate M, Alrohimi A, Singh N, Benali F, Horn M, Buck B, Ademola A, Khosravani H

Journal of NeuroInterventional Surgery20255 citations

DOI: 10.1136/jnis-2025-023336

Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial

Siddiqi AZ, Ignacio K, Kaveeta C, Bala F, Ademola A, Tkach A, Buck BH, Catanese L, Hunter G, Dowlatshahi D

Journal of the American Heart Association20254 citationsOpen Access

DOI: 10.1161/jaha.124.037577 PMID: W4405658451

Tenecteplase versus Alteplase and First-Pass Reperfusion in Endovascular Thrombectomy.

Diprose WK, Bala F, Menon BK, Singh N, Khosravani H, Tkach A, Appireddy R, Horn M, Catanese L, Dowlatshahi D

American Journal of Neuroradiology20254 citations

DOI: 10.3174/ajnr.a8763

Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT Trial

Sujanthan S, Rajkumar G, Dainty KN, Barense M, Lanctot KL, Owen AM, Singh N, Buck BH, Khosravani H, Coutts SB

Stroke20252 citations

DOI: 10.1161/strokeaha.125.051670

Something wrong or missing on this profile? Suggest a correction

Ramana Appireddy

Research

Latest papers

Latest funding

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial.

Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.

Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial

Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial

Intravenous tenecteplase is associated with a higher incidence of thrombus movement before endovascular treatment for acute ischemic stroke: a secondary analysis of the AcT randomized controlled trial

Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial

Tenecteplase versus Alteplase and First-Pass Reperfusion in Endovascular Thrombectomy.

Faster Thrombolysis Is Associated With Improved Cognitive Outcomes in Patients With Acute Ischemic Stroke Treated With Alteplase and Tenecteplase: A Substudy of the AcT Trial

Frequent collaborators

Nishita Singh

Luciana Catanese

Houman Khosravani

Dar Dowlatshahi

Houman Khosravani

Michel Shamy

Mohammed Almekhlafi

Nishita Singh

Aleksandra Pikula

Aravind Ganesh

Brian Buck

Tolulope Sajobi

Bijoy Menon

Ashkan Shoamanesh

Benjamin Ritsma

Andrew Demchuk

Aristeidis Katsanos

Jai Shankar

Mahesh Kate

Kuan Huei Ng

Abhilekh Srivastava

Raed Joundi

Sashi Perera

Richard Swartz

Morgan Barense

Mukul Sharma

Jay Riva-Cambrin

Dariush Dowlatshahi

Alexandre Poppe

Noreen Kamal

Wes Oczkowski